Vaxart, Inc. (VXRT)
0.80
+0.12
(+17.65%)
USD |
OTCM |
Jan 12, 16:00
Vaxart Market Cap: 192.05M for Jan. 12, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Bionano Genomics, Inc. | 16.18M |
| AIM ImmunoTech, Inc. | 3.677M |
| Perspective Therapeutics, Inc. | 179.15M |
| Protalix Biotherapeutics, Inc. | 168.88M |
| Armata Pharmaceuticals, Inc. | 242.68M |
Market Cap Related Metrics
| PS Ratio | 1.232 |
| Price to Book Value | 7.178 |
| Price | 0.80 |
| Earnings Yield | -27.78% |